Log in to save to my catalogue

Development of a live attenuated vaccine against Muscovy duck reovirus infection

Development of a live attenuated vaccine against Muscovy duck reovirus infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2132727622

Development of a live attenuated vaccine against Muscovy duck reovirus infection

About this item

Full title

Development of a live attenuated vaccine against Muscovy duck reovirus infection

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2018-12, Vol.36 (52), p.8001-8007

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

•Muscovy duck reovirus (MDRV) causes infection and economic losses in the Muscovy duck industry.•CA strain was developed as a live attenuated vaccine candidate after serial passages of MDRV virulent strain MW9710.•CA strain is highly immunogenic to protect the ducks from MDRV infection.•A single dose of CA vaccine is sufficient to protect the birds...

Alternative Titles

Full title

Development of a live attenuated vaccine against Muscovy duck reovirus infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2132727622

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2132727622

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2018.10.102

How to access this item